2007 BIO International Convention Exhibitor Profiles Continued, D Through M
Posted on: Thursday, 3 May 2007, 12:00 CDT
2007 BIO International Convention, the Global Event for Biotechnology, takes place May 06 - 09, 2007 at the Boston Convention & Exhibition Center. For in-depth information about the event, visit http://www.bio2007.org/Media/releases.html.
Below are profiles from BIO exhibitors, listed D through M.
Business Wire is the official news wire for 2007 BIO International Convention. Breaking news releases and photos are available at Tradeshownews.com, Business Wire's trade show, conference, and event news resource as well as the official show site.
Company:
D-Pharm Ltd
Media Contact:
thorovitz@dpharm.com
Phone:
97289385100
E-mail:
thorovitz@dpharm.com
Web:
www.dpharm.com
D-Pharm Ltd is a clinical stage company focused on discovery and development of lipid-based therapeutics for CNS disorders and cancer. D-Pharm's most advance product, DP-b99, recently successfully completed a Phase IIb study in acute stroke patients. DP-b99 was found to double the chance to fully recover following stroke. These results will be described by D-Pharm's President and CEO at the Bio 2007 Business Forum in Boston on Wednesday May 9th, Room A at 9.00am.
D-Pharm's other pipeline products include DP-VPA (Phase II) for epilepsy, migraine and bipolar disorder and DP-460 (preclinical) for Alzheimer's disease. Visit www.dpharm.com.
Company:
Dry Ice Corp.
Booth:
600
Media Contact:
Pat Walsh
Phone:
410-536-4939
E-mail:
dpipat@msn.com
Web:
www.dryicecorp.com
Dry Ice Corp. is the largest regional supplier of dry ice products and customized delivery services in the Northeastern U.S. We specialize in supplying the Biotech, Pharmaceutical, and Research industries with a reliable supply of "fresh" dry ice and on-site "desk-top" delivery services.
From Maine to Virginia, you can count on Dry Ice Corp. to provide uninterrupted supply of essential dry ice from one of our six branches located in; Boston, MA--Branford, CT-- Newark, NJ--New York City, NY--Philadelphia, PA and Baltimore, MD.
Visit our web-site at www.dryicecorp.com to learn more about our Total Dry Ice Supply Programs.
Company:
DSM Pharmaceutical Products
Booth:
3021
Media Contact:
Terry Novak
Phone:
973-257-8471
E-mail:
Terry.novak@dsm.com
Web:
http://www.dsmpharmaceuticals.com
DSM Pharmaceutical Products is a global provider of high quality custom contract manufacturing services to the pharmaceutical and biopharmaceutical industries. DSM Pharmaceutical Products provides contract manufacturing services including: advanced intermediates, active ingredients (API's), amino acids and derivatives, mammalian cell culture production (fed-batch and perfusion) of monoclonal antibodies, proteins, vaccines, finished dose manufacturing of solid dose, scheduled drugs, liquids, aseptic liquid and lyophilized products.
From clinical to commercial services, DSM focuses the right resources on providing the highest level of service and quality while applying innovative solutions to satisfy customers' unique manufacturing needs.
Company:
Dynogen Pharmaceuticals, Inc.
Media Contact:
Heather Savelle
Phone:
781.839.5149
E-mail:
hsavelle@dynogen.com
Web:
www.dynogen.com
Dynogen is a clinical-stage company developing a portfolio of treatments for gastrointestinal and genitourinary disorders. The Company is focused on attractive and untapped markets in disease areas that severely impair a patient's quality of life, such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD) and overactive bladder (OAB). Dynogen leverages its development expertise to identify promising clinical compounds and rapidly advance them towards registration.
Dynogen currently has three clinical stage products in various stages of development for five indications:
•DDP733 for IBS with constipation (IBS-c) and NGERD
•DDP225 IBS with diarrhea (IBS-d) and OAB
•DDP200 for OAB
Company:
Economic Development Board, Singapore
Booth:
2533
Media Contact:
Sheo Shanker Rai
Phone:
65 6395 7784
E-mail:
sheo_shanker_rai@bmsg.gov.sg
Web:
www.biomed-singapore.com
The Economic Development Board is Singapore's lead agency responsible for planning and executing strategies to sustain Singapore's position as a compelling global hub for business and investment. The Biomedical Sciences Group oversees the development of Singapore's biomedical sciences industry and supports biomedical sciences companies with manufacturing, research and development, headquarter and other high-value operations in Singapore. www.biomed-singapore.com
Company:
Economic Development San Marcos
Booth:
3065
Media Contact:
Kim Moore
Phone:
512-393-3400
E-mail:
kmoore@ecodevsanmarcos.org
Web:
www.ecodevsanmarcos.org
Economic Development San Marcos (EDSM) is a division of Global Marketeer Group, Inc. under contract with the City of San Marcos, Texas. EDSM serves as a catalyst for job creation, job retention and business investment. San Marcos is located between Austin and San Antonio on Interstate Highway 35 providing interstate and international travel. Location, infrastructure, and market access make San Marcos a successful community for business and industry. Texas State University-San Marcos is the largest university of the Texas State University System with over 27,500 students. Texas State provides a well-trained workforce for the region's growing high tech industry.
Company:
EBD Group
Booth:
1059
Media Contact:
Constantine Theodoropulos
Phone:
617-619-9801
E-mail:
ctheodoropulos@ebdgroup.com
Web:
www.ebdgroup.com
EBD Group is the leading partnering firm for the global biotechnology industry. Since 1993, firms in the life sciences have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships that drive their business.
EBD Group's conferences (run in collaboration with leading industry partners and international trade associations such as BIO and Eucomed) include BIO-Europe, BIO-Europe Spring, BioEquity Europe (co-organized with BioCentury Publications); and the medical technology and BioDevice Partnering. EBD's novel web-based partnering software system is also used at numerous third-party events around the world. Outside of the conference format, EBD Group's consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
Company:
Eden Biodesign
Booth:
3225
Media Contact:
Stéphanie Monfront
Phone:
0207 861 3838
E-mail:
s.monfront@defacto.com
Web:
www.edenbiodesign.co.uk
Eden Biodesign is a world leader in the provision of biopharmaceutical development and manufacturing expertise and now operates the new world class UK National Biomanufacturing Centre.
The combination of the advanced facility and the expertise found in its people, mean Eden Biodesign has the scope and the capacity to handle over 95% of the products and processes found within the biopharmaceutical pipeline.
---Recombinant protein therapies (antibodies and fragments)
---Natural proteins
---Gene therapies
---Cell therapies
---Vaccines (VLP, Cancer vaccines, whole cell vaccines)
---Tissue engineering
Company:
Embera NeuroTherapeutics, Inc.
Booth:
1725 - Louisiana Pavilion
Media Contact:
Stephanie Martin
Phone:
(318) 213-0198
E-mail:
stephanie@emberaneuro.com
Web:
www.emberaneuro.com
Embera NeuroTherapeutics is a specialty pharmaceutical company dedicated to developing and commercializing novel treatments for a broad range of addictions and neuropsychiatric disorders. Embera is preparing to enter clinical trials for EMB-001, a patent-pending drug combination developed for the treatment of addiction and psychiatric disorders. EMB-001 targets the specific neurological pathways associated with craving and relapse and may be effective in treating a wide array of addictions including cocaine, methamphetamine, and alcohol dependence as well as psychiatric illnesses such as anxiety and compulsive behavioral disorders. For additional information regarding EMB-001 and Embera NeuroTherapeutics please visit the company's website: http://www.emberaneuro.com.
Company:
EMC Corporation
Booth:
Booth #533, Pod #A3
Ticker Symbol & Exchange:
EMC, NYSE
Media Contact:
Hadley Weinzierl
Phone:
508 293 7642
E-mail:
Weinzierl_hadley@emc.com
Web:
www.emc.com
EMC Corporation is the world's leading developer and provider of information infrastructure technology and solutions that enable life sciences organizations of all sizes---from pharmaceutical, biotechnology, and medical device, academic research labs, to government organizations --- to transform the way they create value from their information.
EMC representatives will discuss and demonstrate how life sciences organizations can store information more intelligently, leverage content for collaboration and compliance, protect information effectively and affordably, and secure critical assets. EMC will also discuss its information archiving and compliance solutions for emerging and enterprise life sciences organizations.
Company:
Empyrean Management Group
Booth:
2700
Media Contact:
Kristy Boldt
Phone:
610-275-4400
E-mail:
kboldt@HireSmartPeople.com
Web:
www.HireSmartPeople.com
Empyrean Management Group, Inc. (EMG) is a Management Consulting company focused on the most important aspect of any organization, its people. EMG provides Fixed Price/Fixed Time outsourced HR, Recruiting, and Training services on a national basis for clients ranging from Fortune 50 companies to emerging and midsize businesses spanning across many industries. EMG facilitates the design and implementation of systems that attract and retain the best possible employees for our clients.
Inc. Magazine and the Philadelphia Business Journal have recently recognized EMG as one of the fastest growing privately held companies in the US and Philadelphia, PA regions.
Company:
Enterprise Honolulu (Economic Development, Hawaii)
Booth:
687
Media Contact:
Mark Ritchie
Phone:
(808) 521-3611 x11
E-mail:
mritchie@enterprisehonolulu.com
Web:
http://www.enterprisehonolulu.com
Enterprise Honolulu is a private sector economic development organization. We assist life science and other technology companies to grow in Hawaii and to develop global markets. Working with our partner organizations we offer Hawaii companies a range of services, including business planning, financing and business development and expansion assistance. Also, we assist mainland and international companies exploring investment locations for life science projects. Our organization can provide site selectors a wealth of information on Hawaii's competitive advantages as well as coordinate a range of additional services to companies establishing operations in Hawaii.
Company:
ERA Consulting Group
Booth:
774 & 1864
Media Contact:
Mr. Paul Cronin
Phone:
44-20-7510-0200
E-mail:
info@eraconsulting.com
Web:
www.eraconsulting.com
The ERA Consulting Group provides regulatory affairs and product development consulting services, specializing in strategies for biotech and other biological products. We have offices in Germany (near Hannover), UK (London), USA (Washington D.C.) and Australia (Brisbane). Our experience covers over 250 products with input ranging from feasibility studies and advice on regulatory strategy, to the compilation and submission of complete dossiers. Our clients range from virtual biotech companies to the largest pharmaceutical corporations. Our 20-year track record places us in an unrivalled position in this specialized field and provides a level of expertise from which all clients can benefit.
Company:
EuropaBio
Booth:
781
Media Contact:
Adeline Farrelly, Communications Director
Phone:
32 2 735 0313
E-mail:
a.farrelly@europabio.org
Web:
www.europabio.org
EuropaBio's mission is to promote an innovative and dynamic biotechnology-based industry in Europe.
EuropaBio (the European Association for Bioindustries) has 78 direct members operating Worldwide, 12 associate members and 5 bioregions as well as 25 national biotechnology associations representing some 1800 small and medium sized enterprises involved in research and development, testing, manufacturing and distribution of biotechnology products.
Company:
European Pavilion
Booth:
773
Media Contact:
Stephane Hogan
Phone:
32 2 296 2965
E-mail:
stephane.hogan@ec.europa.eu
Web:
www.ec.europa.eu/research/eu-bio2007
The EU Joint Delegation at BIO 2007 consists of experts and high level policy makers from the European Commission, the executive arm of the EU, the European Patent Office (EPO) and the European Medicines Agency (EMEA). Through its participation in the BIO International Convention, the EU Joint Delegation will present current developments in biotech in the EU relevant for the global industry: policy, regulation, scientific cooperation and funding. It will be headed by Mr. John Bruton, the European Union Ambassador to the USA. The EU Pavilion (booth number 773) features representatives of the EC, EMEA and EPO.
Company:
Evotec
Booth:
UK Pavillion - Booth 1660 & German Pavillion - Booth 555
Ticker Symbol & Exchange:
EVT
Media Contact:
Sarah Herrmann
Phone:
0207 867 3838
E-mail:
s.herrmann@defacto.com
Web:
www.evotec.com
Evotec AG (FSE: EVT) is a leader in the discovery and development of novel small molecule drugs. The Company has built a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System (CNS) related diseases where it is building a pipeline of drug candidates for partnering.
Through its collaborations and proprietary projects Evotec is providing the highest quality research results to its partners:
--In proprietary projects, Evotec specialises in finding new treatments for diseases of the Central Nervous System.
--In collaborations, Evotec has established itself as the partner of choice for pharmaceutical and biotechnology companies worldwide.
Company:
Favrille, Inc.
Ticker Symbol & Exchange:
Nasdaq: FVRL
Media Contact:
Pete De Spain
Phone:
(858) 526-2426
E-mail:
pdespain@favrille.com
Web:
www.favrille.com
Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, FavId, is based upon unique genetic information extracted from a patient's tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional applications based on its immunotherapy expertise and proprietary cost-effective manufacturing technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.
Company:
FLAMMA Sas
Booth:
2025 - Italy Pavilion
Phone:
33 1 55 52 14 50
E-mail:
Fabrice.cornille@flamma.fr
Web:
www.flamma.it
FLAMMA is a manufacturer founded in 1950 and based in Bergamo/Italy with specific expertise in the field of AA derivatives & related compounds. Company expertise ranges from the production of AA derivatives classified as starting materials/key intermediates, to the related compounds classified as active pharmaceutical ingredients.
Currently FLAMMA operates also in France with the marketing subsidiary Flamma sas and in P.R. China with the manufacturing joint-venture Flamma Gongan Biochemicals Co. Ltd for the production of some basic amino-acids and with a fully owned Research & Technology Center in Shanghai, Shanghai Flamma Bioscience Co. Ltd.
Company:
Florida Biologix
Booth:
1743 Florida Pavillion
Media Contact:
Jim Ayala- Director of Business Development
Phone:
386-418-8199 ext 203
E-mail:
jayala@floridabiologix.ufl.com
Web:
www.floridabiologix.ufl.com
Florida Biologix is non--profit Contract Manufacturing Organization (CMO) that offers a wide range of biopharmaceutical development and manufacturing services to the biotechnology industry and to biomedical research institutions, including: cell line engineering, cGMP cell banking, upstream and downstream processes design, process and assay development, cGMP production of proteins expressed in mammalian cells (including monoclonal antibodies, recombinant proteins, enzymes, vaccines, and other biomolecules), purification, aseptic filling (including small molecules, nucleic acids, and proteins), product testing, and regulatory support. Products made in this facility are suitable for pre-clinical, and Phase I and II human clinical trails.
Company:
Florida High Tech Corridor Council
Booth:
1743
Media Contact:
Justin Campfield
Phone:
(407) 423-8006
E-mail:
jcampfield@thestrategicfirm.com
Web:
www.FloridaHighTech.com
The Florida High Tech Corridor Council (FHTCC) is an economic development initiative of the University of Central Florida, the University of South Florida and the University of Florida whose mission is to attract, retain and grow high tech industry in the 23-county Corridor.
A partnership of more than 20 local and regional economic development organizations (EDOs) and 14 community colleges, FHTCC employs a strategic approach to high tech economic development that involves matching funds research, workforce development and a marketing program leveraging governmental, EDO and corporate budgets on a regional rather than local basis.
Company:
Foamix Ltd.
Booth:
3171
Media Contact:
Dov Tamarkin
Phone:
972-8-9316233
E-mail:
dov@foamix.co.il
Web:
www.foamix.co.il
Foamix develops proprietary topical foam products for dermatology, gynecology, wound and burn care. By incorporating drugs in foam, we create premium products with improved convenience, higher compliance and better efficiency of treatment. We currently collaborate with 8 pharmaceutical companies in the development of proprietary foam drugs; and we have our in-house pipeline of dermatological and gynecological drugs in foam.
The Foamix foam delivery platforms include:
1. Oil in water emulsion foam (cream-like)
2. Water in oil emulsion foam (occlusive-cream-like)
3. Waterless hydrophilic foam (hydrophilic-ointment-like)
4. Oily foam (with or without water)
5. Petrolatum based foam (ointment-like)
6. Suspension foam
Company:
Formatech, Inc.
Booth:
533-D7
Media Contact:
Jeffrey Bernard
Phone:
978-725-9077
E-mail:
jbernard@formatech.com
Web:
www.formatech.com
Formatech is a dedicated contract service provider that excels delivering unique solutions to our client's product development and manufacturing challenges.
Our development services include preformulation & formulation development of all common dosage forms, cell culture/fermentation development and purification/downstream process optimization.
Developing biotherapeutic products is one of Formatech's strengths. Our accomplishments include developing Ab formulations at concentrations in excess of 200 mg/mL and an orally bioavailable peptide formulation.
Our aseptic manufacturing facility produces liquid & lyophilized dosage units for clinical supplies or small scale commercial products. Manufacturing support services include compounding/formulation, diafiltration/concentration (UF/DF), release testing, and full ICH Guideline Stability Programs.
Company:
Fritz Gyger AG
Booth:
1919, Swiss Biotech Pavilion
Media Contact:
Barbara Rohner-Gunziger
Phone:
41 (0)33 336 22 77
E-mail:
sales@fgyger.ch
Web:
www.fgyger.ch
Fritz Gyger AG was founded in 1959 in Switzerland.
Since 1992, High Speed Micro Solenoid Valves have been developed and produced, with ultra-hard materials as their key elements. The newest generation of modular SMLD valves find their application for example, in the fields of analysis technology and nano litre dispensing devices. The technology of Gyger sets new standards with reference to miniaturization, liquid metering accuracy and lifetime.
The development and manufacturing of functional modules for HPLC pumps makes Gyger a strong partner in this field.
Gyger offers a service to fulfil the need of customised solutions for micro dispensing systems.
Company:
Frontier BioSciences, Inc.
Booth:
688
Media Contact:
Beth Wong, AVP, Business Development
Phone:
240-372-2100
E-mail:
bwong@frontierbsi.com
Web:
http://www.frontierbsi.com/
Frontier BioSciences, Inc. is a MD-based company providing preclinical CRO services in Chengdu, China. With its partner, the National Chengdu Center for Safety Evaluation of Drugs, it provides preclinical toxicology services, including PK/TK, Animal Models, General Toxicology, Developmental & Reproductive Toxicology, Safety Pharmacology, and Genetic Toxicology, supported by in-house bioanalytical, clinical pathology, and histopathology services. The state-of-the art toxicology facilities encompass 80,000 sq. ft. and are equipped with the latest advanced technology and are operated by highly-trained and experienced staff with international CRO experience.
Company:
Fundacion Biociencia
Booth:
2771 Chile Pavilion
Media Contact:
Olivier Rickmers
Phone:
56 2 343 25 78
E-mail:
orickmer@bioscience.cl
Web:
www.bioscience.cl
High-Knowledge Institution specialized on Extremophiles R&D.
Company:
Fusion Antibodies
Booth:
1875
Media Contact:
Dr Paul Kerr
Phone:
4477929734619
E-mail:
Paul.kerr@fusionantibodies.com
Web:
www.fusionantibodies.com
Fusion Antibodies is a biotechnology company focused on the discovery, development and commercialisation of antibody-based therapeutics for cancer & angiogenesis.
Fusion also provides contract services for the rapid expression & purification of recombinant proteins, antibody sequencing and antibody engineering for the research, diagnostic and therapeutic markets.
Company:
Genome Prairie
Booth:
#823 -- Manitoba-Canada Pavilion
Media Contact:
Carol Reynolds
Phone:
(306) 241-9033 / cell (306) 668-3574
E-mail:
creynolds@genomeprairie.ca
Web:
www.genomeprairie.ca
Genome Prairie (www.genomeprairie.ca) is the leading organization for support and management of large-scale genomics and proteomics research projects in Manitoba and Saskatchewan, Canada. With its partners, Genome Prairie has supported more than $120 million of research activity in plant, animal and human genomics, bioinformatics, instrumentation development and bioethics since 2000.
Current research projects led by Genome Prairie include the North American Conditional Mouse Mutagenesis (NorCOMM) Project (www.norcomm.org) and the Crop Adaptation Genomics Project (www.cropadaptationgenomics.ca) involving frost-tolerant wheat.
Genome Prairie works collaboratively with all levels of government, universities and industry provincially, nationally and internationally to advance genomics and proteomics research.
Company:
genOway
Booth:
French pavilion-1207
Phone:
33 437 65 41 00
E-mail:
info@genoway.com
Web:
www.genOway.com
Operating in Europe, North America and Asia, genOway proposes time saving and cost effective strategies for in vivo drug development programs. Focusing its effort on the mouse and rat, genOway has developed a complete range of innovative technological solutions to create a new generation of customized transgenic models. genOway's expertise combines technologies classically used in transgenesis and several cutting-edge proprietary technologies aiming at enhancing the efficiency, security and relevance of the tailor-made animal model ultimately developed.
Moreover, genOway license policy allows his clients to have a free use of the model developed for target validation and drug discovery purposes.
Company:
GenScript Corporation
Booth:
1023
Phone:
732-885-9188
E-mail:
info@genscript.com
Web:
www.genscript.com
As a pioneer of the life science research service industry, GenScript Corporation has developed, reliable and innovative techniques, rock-solid quality control, and a one-stop service package that provides quality gene, peptide, protein, and antibody products and services at competitive prices. Our services include gene synthesis, cloning and mutagenesis, protein expression and purification, antibody production, and gene functional analysis.
GenScript's business philosophy has always been to satisfy the customer's needs through adaptation and experience. GenScript is proud to participate in the 2007 BIO International Convention and looks forward furthering partnerships with customers, business peers, and other members of the biotechnology community.
Company:
GlaxoSmithKline Biopharmaceuticals
Booth:
1160
Ticker Symbol & Exchange:
GSK
Media Contact:
Anthony J Zuazo
Phone:
610 239 3887
E-mail:
gsk.biopharm@gsk.com
Web:
www.gsk.com/biopharm
GSK Biopharmaceuticals is a full-service provider in the development and cGMP preparation of biopharmaceutical proteins for clinical trials and the marketplace. Our services include the low-cost, rapid scale-up and manufacture of mammalian cell derived proteins at up to 5,000L scale and the preparation of formulated bulk products.
Company:
GLW Storing Systems
Booth:
658
Media Contact:
Mrs. Astrid Hartenstein
Phone:
49 931 6677 210
E-mail:
info@glw-storingsystems.com
Web:
www.glw-storingsystems.com
GLW is a privately owned company in Northern Bavaria, specialized in sample storage systems (plastics, metal) for long-term storage, deep freezing and transportation.
Company:
GlycoGene, Inc.
Booth:
2549-Japan Pavilion
Media Contact:
Tadayoshi Kawasaki, Ph.D., President & CEO
Phone:
81-(0)29-855-1080
E-mail:
Tadayoshi-Kawasaki@aist.go.jp
Web:
http://www.glycogene.co.jp
We can provide services of 1) Oligosaccharide synthesis, 2)Glycan analysis, 3)Screening of Biomarkers, 4) Glyco-engineering, and 5) Biopharmaceutical development by modifying the glycans.
GlycoGene, Inc., will provide services of Oligosaccharide synthesis, either N-glycan or O-glycan by use of over 180 human glycosyltransferases. Also we can provide services of glycan analysis of glycoproteins. We also are working on the Screening of Biomarkers which related to glycan, glycosyltransferases and the genes. We are interesting to have collaboration with pharmaceutical companies to develop a biopharmaceuticals with use of Glyco-engineering, either a new one or a biosimilar.
Company:
Glycotope GmbH
Booth:
565
Media Contact:
Dr. Hans Baumeister
Phone:
49-(0)30 941 084 207
E-mail:
Hans.baumeister@glycotope.com
Web:
www.glycotope.com
Glycotope -- the GlycoEngineering Company - has specialized in exploring the glycosylation machinery and health related significance of sugar structures on proteins and on microorganisms. Based on GlycoExpress, a proprietary human cell-line to generate fully human glycosylated proteins with optimized sialylation degrees, we develop own glycoproteins for therapeutic use, tumor specific antibodies and vaccines, as well as nutraceuticals with specific health characteristics. Furthermore, the company offers services in form of integrated glycoengineering and antibody engineering solutions.
Company:
Government of Canada BioPortal
Booth:
Booth #815 / Government of Canada Pavilion
Media Contact:
Joshua Belinko
Phone:
613-954-7737
E-mail:
Joshua@biotech.gc.ca
Web:
http://biotech.gc.ca
The highly acclaimed Government of Canada BioPortal is designed for scientists, researchers, business people, consumers, regulators, and anyone interested in biotechnology. It is the definitive source for information on Canada's biotechnology regulations, investment and business opportunities, government policies and research activities, public opinion, and consultation activities on key issues. See http://biotech.gc.ca.
Company:
GP Pharm
Booth:
988
Media Contact:
Xavier Vergés
Phone:
0034936388000
E-mail:
xverges@gp-pharm.com
Web:
www.gp-pharm.com
GP Pharm is located in Barcelona (Spain). Our activities are focused on development of injectable products within Urology and Oncology fields, some based in own Drug Delivery Systems. These technological platforms include microspheres and liposomes.
The company works in the complete development of these drugs, from preclinical studies until the launch to the market. These specialities will be marketed either under own brands or through licenses. The new production plant of GP Pharm recently achieved EU GMP approval and started manufacturing operations, being also designed to be FDA GMP approved.
Company:
Greater Dallas Chamber Technology Business Council
Media Contact:
Jo Trizila
Phone:
214-746-6690
E-mail:
jtrizila@dallaschamber.org
Web:
www.DallasTBC.org / www.BioDFW.org
The Greater Dallas Chamber's Technology Business Council promotes Dallas/Fort Worth as a world-class technology center and provides the region with a vehicle to effectively assemble all parties related to its technology resources and infrastructure. This objective supports the Chamber's overall mission of enabling continual business growth throughout North Texas while helping the region maintain its technology preeminence on a national scale. There are a host of issue-specific council groups, events and affiliated opportunities for participation through the Technology Business Council investment. For more information, please visit www.DallasTBC.org or contact tech@dallaschamber.org.
BIODFW fosters an open, entrepreneurial environment that encourages growth and innovation; develops an information clearinghouse of relevant regional resources in the life sciences; and supports regional economic development endeavors in the life science arena. BioDFW's goal is to be the primary vehicle that establishes the North Texas region as a global competitor in the life science industry and to foster an ideal climate for entrepreneurs, researchers, industry management and staff, faculty, students and related business suppliers. BIODFW offers a monthly breakfast series featuring keynote speakers focused on business issues and opportunities in the life science industry. For more information on BioDFW's initiatives, please visit www.BioDFW.org.
Company:
Greater Phoenix Economic Council
Booth:
Arizona Pavilion -- Booth #2255
Media Contact:
Linda Brady
Phone:
602-350-8809
E-mail:
lbrady@gpec.org
Web:
www.gpec.org
Greater Phoenix's diverse economic base, highly skilled workforce and strong business climate position us firmly among the most competitive regions in the world.
When you are faced with obtaining the facts you need to make the right decision on relocating or expanding your business, GPEC is your resource.
Our team of expansion and relocation specialists confidentially help you obtain all the facts you need to thoroughly evaluate the region. We save you countless hours of research and analysis by providing a full complement of services, all at no cost or obligation to you.
Contact GPEC for more information: 800.421.4732.
Company:
Greater Tampa Chamber of Commerce
Booth:
1743 (Enterprise Florida Pavilion)
Media Contact:
Chris Smith, Vice President Public Policy
Phone:
(813) 276-9455
E-mail:
csmith@tampachamber.com
Web:
http://www.tampachamber.com/economic_development.asp
The Greater Tampa Chamber of Commerce Committee of One Hundred (C100) is Tampa/Hillsborough County's official economic development partnership, funded by Hillsborough County, the cities of Tampa, Plant City, and Temple Terrace, and private sector investors. C100 provides confidential site selection services for life science business expansion and relocation projects. http://www.tampachamber.com/economic_development.asp
Company:
GTC Biotherapeutics
Booth:
# 533 / Pod# 23
Ticker Symbol & Exchange:
GTCB
Media Contact:
Thomas Newberry
Phone:
508-370-5374
E-mail:
thomas.newberry@gtc-bio.com
Web:
www.gtc-bio.com
GTC Biotherapeutics develops, produces, and commercializes therapeutic proteins through transgenic animal technology. ATryn®, our recombinant form of human antithrombin, is the first transgenically produced protein to be approved anywhere in the world, having recently been approved by the European Commission for the prophylactic treatment of deep vein thrombosis in patients with hereditary antithrombin deficiencies that are undergoing surgical procedures. In addition to ATryn®, GTC is developing additional recombinant forms of therapeutic proteins normally found in human blood plasma as well as monoclonal antibodies. These products have potential applications in hematology, oncology, and autoimmune diseases. Additional information is available at http://www.gtc-bio.com.
Company:
Hawaii Life Sciences
Booth:
687
Media Contact:
Elizabeth Corbin
Phone:
(808) 255-1560
E-mail:
ecorbin@dbedt.hawaii.gov
Why Hawaii? Unique marine & terrestrial biodiversity throughout the Hawaiian islands; Outstanding capability for biofuels development; Ethnically diverse state, ideal for clinical trials; Excellent work force; Venture capital availability; Nation's most generous high technology investment and R&D tax incentives; Strategic Asia-Pacific location.
Company:
HealthCare Institute of New Jersey
Booth:
New Jersey Pavilion
Media Contact:
William Healey/EVP or Hollie Gilroy, Director of communications
Phone:
908-334-7229(Healey) or 908-212-0333 (Gilroy)
E-mail:
healey@hinj.org / gilroy@hinj.org
Web:
www.hinj.org
The HealthCare Institute of New Jersey (HINJ) is headquartered in Bridgewater, in the heart of the Garden State's pharmaceutical and medical technology core.
HINJ represents 33 of the largest researched-based pharmaceutical and medical technology firms, virtually all of whom call NJ their world or North American headquarters. HINJ members employ more than 60,000 persons in the state and 100,000 indirectly in spin-off jobs.
Company:
Helix BioMedix, Inc.
Ticker Symbol & Exchange:
OTCBB: HXBM
Media Contact:
Alison Ziegler, Investor Relations
Phone:
212-554-5469
E-mail:
Alison@cameronassoc.com
Web:
www.helixbiomedix.com
Helix BioMedix, Inc. is a biopharmaceutical company with a vast library of diverse bioactive peptides. The company's mission is to enrich clinical practice and the patient and consumer experience by expanding opportunities to tap the health, beauty and safety benefits of advanced bioactive small molecule technology. Our vision is to be recognized as the world leader in the identification, qualification and commercialization of natural and synthetic peptide technology. Applications for Helix BioMedix peptides include anti-aging cosmeceutical skin care, acne treatment and other topical anti-infective pharmaceuticals and wound healing. More information may be found on the company's website at www.helixbiomedix.com.
Company:
HENOGEN SA
Booth:
2480
Media Contact:
Marc Gesnot
Phone:
32 71 34 79 00
E-mail:
marc.gesnot@henogen.com
Web:
www.henogen.com
Henogen is a multipurpose biotech facility addressing bio-manufacturing issues and has extensive knowledge in performing and/or accompanying partners through the process development and cGMP production up to phase III.
--cGMP BL2/BL3 facilities including fill and finish.
--European-wide agreement No. 1535 for manufacturing pharmaceutical products.
--Track records: r-proteins, subunit and live attenuated vaccines, monoclonal antibodies, viral vectors,
--"Elite European Company" (critical/comparative study of Biotech Companies, EuropaBio 2006).
Bio-manufacturing capabilities:
--Microbial fermentation (150L).
--Mammalian & Insect cell culture (80L perfusion, 300L fed batch).
--Virus production.
Company:
High Resolution Engineering
Booth:
3058
Media Contact:
Ann Bellinger
Phone:
781 932 1912
E-mail:
abellinger@hireseng.com
Web:
www.hireseng.com
High Resolution Engineering provides world class engineering services for the life science community. Our MicroCell is designed for unmatched reliability and features self identifying, dockable carts paired with innovative docking stations. Our multithreading, dynamic scheduling algorithm, Cellario will improve your assay scheduling timings and is easy to use.
Company:
HistoRx, Inc.
Booth:
1371
Media Contact:
John Tonkinson, PhD
Phone:
203-498-7500 x220
E-mail:
jtonkinson@historx.com
Web:
www.historx.com
HistoRx analyzes biomarkers in situ using a platform capable of measuring biomarker concentration with subcellular resolution in tissue sections and tissue microarrays. HistoRx forms partnerships with pharmaceutical companies to develop biomarker assays and companion diagnostic tests. With the results from AQUA® analysis scientists have, for the first time, highly quantitative, standardized and reproducible IHC results. HistoRx sells the PM-2000™ instrument and AQUA® software, the most advanced quantitative fluorescent immunohistochemical analysis of tissue microarrays/sections available, to academic and not-for-profit research institutions for noncommercial use. With proprietary AQUA® algorithms, the guesswork is taken out of IHC.
Company:
Health Protection Agency
Booth:
1776
Media Contact:
Dr Phil Luton
Phone:
44 (0) 7887 656001
E-mail:
business@hpa.org.uk
Web:
www.hpa.org.uk/business
The UK's Health Protection Agency was formed in 2003 to provide a coordinated response to emerging chemical, radiological and biological health threats, including the threat of bioterrorism. The Agency has over 3000 staff in 3 national Centres, as well as at regional and local levels who work to "Protect People, Prevent Harm and Prepare for Threats".
We undertake research and development of vaccines and therapeutics against infectious diseases, including work for the US National Institute of Allergy & Infectious Diseases, as well as testing of diagnostics, the running of emergency training exercises and the manufacture a number of healthcare products.
Company:
Hydra Biosciences
Media Contact:
Russell Herndon
Phone:
617 494 5230
E-mail:
rherndon@hydrabiosciences.com
Web:
www.hydrabiosciences.com
Hydra Biosciences is a development stage biopharmaceutical company based in Cambridge, Massachusetts. Hydra is developing novel small molecules for the treatment of pain, inflammation, cardiovascular and other diseases by focusing on a new target class: Transient Receptor Potential (TRP) ion channels. The TRP superfamily is a recent discovery and Hydra's team includes the world-leaders in electrophysiology and TRP channel biology. Hydra's two lead programs have been tested in 6 different pre-clinical pain models and have shown excellent efficacy, without the debilitating side effects that exist with current pain therapeutics. These unique programs are targeted at the $20B pain market.
Company:
Ichor Medical Systems, Inc.
Media Contact:
Tom Gable, Gable PR
Phone:
877-251-3888
E-mail:
tom@gablepr.com
Web:
www.ichorms.com
Ichor has developed a patented one-step electroporation system that provides rapid, effective and reproducible administration of DNA drugs and vaccines with minimal operator training or skill. The integrated and fully-automated Ichor TriGrid(TM) Delivery System allows the site of injection, placement of electrodes, rate of agent administration, and timing of electroporation delivery to be controlled in a user independent fashion. As a result, Ichor's technology makes the clinical application of electroporation easy, safe, efficient, and totally compatible with the development and commercialization of DNA-based products, enhancing DNA uptake by several orders of magnitude compared to conventional methods of delivery.
Company:
ICON plc
Booth:
2923 & 2925
Ticker Symbol & Exchange:
ICLR on NASDAQ
Media Contact:
Erica Hill
Phone:
215-616-3286
E-mail:
hillE@iconus.com
Web:
www.iconclinical.com
ICON is a full service clinical research organization providing a comprehensive range of clinical services in Phase I-IV clinical trials to the pharmaceutical, biotechnology and device industries. With 52 offices in 30 countries across the globe, ICON has the infrastructure necessary to take on global mega trials, but remains flexible enough to provide development services on a stand-alone basis or as part of an integrated "full-service" solution for locally managed projects.
ICON has one of the most experienced regulatory groups in the industry, with a proven track record of success in regulatory submissions and regulatory agency/authority interactions.
Company:
IDT
Booth:
1310 and 2133
Media Contact:
Chris Henneghan
Phone:
610-269-2100 x237
E-mail:
chenneghan@schubert.com
Web:
www.idtdna.com
Integrated DNA Technologies, Inc. (IDT) is the largest supplier of custom nucleic acids in the U.S., serving the areas of academic research, biotechnology, clinical diagnostics and pharmaceutical development. IDT's primary business is the manufacturing of custom DNA and RNA oligonucleotides (oligos) for research applications.
With more than 400 employees, IDT synthesizes and ships an average of 36,000 custom oligos per day and has more than 77,000 customers worldwide.
IDT is headquartered in Coralville, Iowa, has a production center in San Diego, California and recently acquired Belgian manufacturer RNA-TEC.
The company plans to open its third facility later this year in Leuven, Belgium.
Company:
IKERCHEM LTD
Booth:
1085
Phone:
(34) 943 015381
E-mail:
ikerchem@ikerchem.com
Web:
www.ikerchem.com
IkerChem LTD with a wide expertise on the fields of cycloadditions, microwave-assisted organic synthesis and computational chemistry offers the best solutions in your design, synthesis or R&D projects.
IkerChem has confidential collaboration agreements with highly specialized laboratories to provide support and services in the following areas:
•Contract R&D
•Custom synthesis
•Computation Service
Company:
Image Reading Center
Booth:
1833
Media Contact:
Mark Punyanitya
Phone:
212-523-2487
E-mail:
Bio2007@imagereadingcenter.com
Web:
www.imagereadingcenter.com
The Image Reading Center is one of the premier Imaging Core Laboratories in the world, specializing in the advanced analysis of MRI, DXA, and CT scans for body composition assessment. The IRC utilizes high-resolution imaging for whole body (muscle, fat) and organ specific protocols (cardiac, brain, liver, kidney, spleen, and pancreas). Study design and conduct, site training and oversight, data management and quality control services are available for Phase I/II/III, national and international multi-center studies.
Company:
ImmigrationOptions.com -- Savitz Law Offices, P.C.
Booth:
1969
Media Contact:
Bennett Savitz
Phone:
617-723-7111
E-mail:
Bsavitz@ImmigrationOptions.com
Web:
www.ImmigrationOptions.com
Savitz Law Offices, P.C. (www.ImmigrationOptions.com) provides legal services and expertise in all areas of immigration law both for corporate clients and individuals. In addition to obtaining temporary visas and permanent residence (Green Card) for foreign nationals, we help clients to file to become naturalized U.S. Citizens, and to solve specific problems with the Immigration Service or other government agencies. We have extensive experience working with the myriad of government entities involved in immigration matters, and have developed a worldwide network of contacts and other resources in order to assist our clients on any matter, from the routine to the extraordinary.
Company:
ImmunoGenetix Therapeutics, Inc.
Booth:
2619 (Kansas Pavilion)
Media Contact:
Jim Laufenberg
Phone:
888.744.9246
E-mail:
jbl@igxbio.com
Web:
www.ImmunoGenetix.com
ImmunoGenetix Therapeutics, Inc. is a biotechnology company developing advanced DNA immunotherapies for HIV infection. The Company's lead product candidate, GenePro™, is a DNA therapeutic vaccine incorporating a proprietary DNA construct that yields high levels of gene expression and non-infectious HIV protein production. GenePro™ induces a robust antibody and cellular immune response in animal models, without protein or viral vector boosts.
Company:
Indy Partnership, The
Booth:
1555
Media Contact:
Todd McCall
Phone:
317-965-7989
E-mail:
tmccall@indypartnership.com
Web:
http://www.indypartnership.com
The Indy Partnership is a regional economic development organization charged with spurring capital investment and job growth. Our staff aggressively markets the region to bring in new businesses, investments and jobs. We serve as a regional point-of-contact for responding to business development inquiries and generating good sales leads.
Recent Life Science success:
--Oxford BioSignals have announced plans to move their global headquarters to Carmel, Indiana
--Beckman Coulter announced that they will be moving a centrifuge operation to central Indiana
--Indianapolis MSA ranks # 9 in total biosciences employment - Biotechnology Industry Organization and Battelle Memorial Institute 2007.
Company:
Informa Healthcare
Booth:
1813
Media Contact:
Vanessa.cheung@informa.com
Phone:
44 20 7017 6980
E-mail:
Vanessa.cheung@informa.com
Web:
www.informahealthcare.com
Informa Healthcare serves the commercial needs of business leaders, the research needs of the scientific and academic communities and the "good practice" needs of healthcare professionals. As the most dynamic new publishing group serving the life science and medical markets, we offer a unique range of publishing formats, from major online databases and news services to research and review journals and books.
Exhibiting at BIO 2007 this year are Scrip Publishing, PharmaProjects, BioTechniques and Expert Opinion. Visit our booth 1813 for your FREE samples and demos or to speak to one of our representatives.
Company:
Innovive Inc
Booth:
3034
Media Contact:
Jim Fallon
Phone:
858 309 6631
E-mail:
jim@innoviveinc.com
Web:
www.disposablecages.com
Bring your animal work in house with the Innovive® System, the first fully disposable, irradiated rodent caging solution. Imagine a Turnkey Vivarium: No Washing, No Autoclaving, No Bottle Filling.
By eliminating cage washing and sterilization the Innovive® System simplifies vivarium operations, eliminates capital equipment requirements, and significantly reduces animal housing costs.
The Innovive® System is a state of the art, modularized, ventilated racking system that can be located anywhere in your facility without the need for a wash room. Your researchers will appreciate having access to their animals when and where they need them. WWW.DISPOSABLECAGES.COM
Company:
Inspire Pharmaceuticals
Booth:
NC Pavilion
Ticker Symbol & Exchange:
Nasdaq: ISPH
Media Contact:
Jenny Kobin
Phone:
919-287-1219
E-mail:
jkobin@inspirepharm.com
Web:
www.inspirepharm.com
Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products in disease areas with significant commercial potential and unmet medical needs.
Inspire employs a U.S. sales force for the promotion of AzaSite™ (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis, Elestat® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and Restasis® (cyclosporine ophthalmic emulsion) 0.05% for dry eye. Inspire is focused on the therapeutic areas of ophthalmology and respiratory/allergy, and is developing products for dry eye, cystic fibrosis, allergic rhinitis and glaucoma.
Company:
Institute of Cancer Research, The
Booth:
1864
Media Contact:
Jennifer Hodgson
Phone:
020 7153 5532
E-mail:
jhodgson@icr.ac.uk
Web:
www.icr.ac.uk
The Institute of Cancer Research works in a unique partnership with The Royal Marsden NHS Foundation Trust (the world's oldest cancer hospital) to form Europe's leading and largest comprehensive cancer centre. The joint research strategy and day to day interactions between researchers and clinicians ensure that discoveries made in The Institute's laboratories are swiftly translated into treatment and care for those affected by cancer. The Enterprise Unit has a range of collaboration and out licensing opportunities to offer interested parties, please call by the London Universities stand at BIO for more information.
Company:
Institute of Gene and Brain Science
Booth:
Japan Pavilion 2549 / a9
Media Contact:
Hirotsugu Watabe
Phone:
81(3)5746-1333
E-mail:
info@ins-gbs.co.jp
Web:
http://www.ins-gbs.co.jp/en/index.html
The Institute of Gene and Brain Science is a drug discovery venture company.
We are developing innovative drugs and therapeutic techniques for two disease areas (to refer the followings) based on the research and medical findings of the central nervous system and brain tumors obtained by Dr. Masahiro Toda, a neurosurgeon, in addition to the basic medical findings in the field of immunology.
--Regeneration of central nervous system for central nerve damage and disease (spinal cord injury, cerebral infarction etc.)
--Cancer immune therapy
Company:
Integrated Project Management Company, Inc.
Booth:
Massachusetts Pavillion, Booth 533, Stand D25
Media Contact:
Claudia Kovitz, CRK Communications LLC
Phone:
847-328-8119
E-mail:
crkovitz@sbcglobal.net
Web:
www.ipmcinc.com
"Project management" doesn't sound sexy, but it's fast becoming a key competitive strategy in the biopharmaceutical industry, helping companies perform more efficiently and effectively. Illustrating this trend: Integrated Project Management Company, a leading provider of professional project management services to the life sciences industry, has quadrupled its biotech and pharmaceutical clientele in less than five years, with the pace ever-quickening. IPM vice president Tim Noffke has become a thought-leader on such topics as streamlining product development (his team helped one global company cut time-to-market in half), sound alliance management and creative problem-solving.
Company:
INTERES Invest in Spain
Booth:
979
Phone:
34 91 503 5800
E-mail:
interes@interes.org
Web:
www.investinspain.org
SPAIN: FOR BIOTECHNOLOGY.
--The Spanish biotechnology sector is growing four times faster than the EU-15 average.
--Multinational companies such as GSK, Lilly, Merk Serono o MSD have RD and production centers in Spain.
--Increasing public and private investment and efficient technology transfer.
INTERES Invest in Spain is the leading government organization that supports foreign enterprises seeking to set up or expand their business in Spain. We offer comprehensive, efficient and confidential consultation at no cost during all stages of the investment process. Visit our stand at BIO: Your first port of call for investing in Spain.
Company:
inVentiv Health
Booth:
1220
Ticker Symbol & Exchange:
VTIV
Media Contact:
Felicia Vonella
Phone:
212.308.7155
E-mail:
fvonella@inventivhealth.com
Web:
www.inventivhealth.com
inVentiv Health (NASDAQ: VTIV) is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health currently works with over 200 unique pharmaceutical, biotech and life sciences clients, including all top 20 global pharmaceutical companies. For more information, visit www.inventivhealth.com.
Company:
Invest in Germany
Media Contact:
henkel@invest-in-germany.com
Phone:
(617) 401 2120
E-mail:
hermann@iic.de
Web:
www.invest-in-germany.com
Invest-in-Germany (IiG) is the German federal investment promotion agency which informs, assists and consults foreign investors pursuing business opportunities in Germany. IiG provides full service support in the implementation of investment decisions, including comprehensive market analysis, specific information on business costs, and professional guidance with site analysis. Companies planning to establish or expand business operations in Germany can obtain detailed information on tax regulations, regional and federal financial support, and other aspects of the German corporate environment. IiG's services are free of charge.
Contact US: Palo Alto, Chicago, Washington and new in Boston: 1 Broadway Cambridge MA 02142, Phone: 6174012120.
Company:
Invitrogen
Booth:
239
Ticker Symbol & Exchange:
IVGN
Media Contact:
Eric Endicott
Phone:
760-268-7438
E-mail:
eric.endicott@invitrogen.com
Web:
www.invitrogen.com
Invitrogen Corporation provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company is celebrating 20 years of accelerating scientific discovery. Invitrogen globally employs approximately 4,300 scientists and other professionals and had revenues of more than $1.15 billion in 2006.
Company:
Iowa Department of Economic Development
Booth:
Iowa Pavilion (1340 -- 1361)
Media Contact:
Kay Snyder, Communications Manager -- Nickelle Stevens, The Integer Group
Phone:
515-360-2209 / 515-710-2618
E-mail:
nstevens@integermidwest.com
Web:
www.iowalifechanging.com
Iowa offers the ideal expansion solution for bioscience companies. For investors looking to create beneficial public/private partnerships, Iowa is the smart choice. And for 1,800 bioscience establishments, Iowa is already an exciting place to do business. The state is home to three public universities that are world renowned for their life sciences research. Iowa leads the nation in the production of renewable energy and raw biomass. A competitive economic development incentives program and the opportunity to achieve a balanced personal life are just a few reasons to take a closer look at Iowa. Stop by the Iowa Pavilion, or visit www.iowalifechanging.com to learn more.
Company:
IPS Research Company
Booth:
2233
Media Contact:
Fred Lee
Phone:
405-235 8188
E-mail:
flee@ipsresearch.com
Web:
www.ipsresearch.com
At IPS Research Company we strive to collect the highest quality data through consistent good clinical practice. We are proud of our proven ability to recruit, enroll and retain patients for our clients.
We are continually looking for better ways to serve our clients. With over 50 years combined research experience, our team of clinicians takes pride in the services we provide.
At IPS Research Company we strive to build a partnership with our pharmaceutical clients and our patients to achieve the finest clinical trial performance.
Company:
Isotechnika Inc.
Booth:
720
Ticker Symbol & Exchange:
TSX:ISA
Media Contact:
Stephanie Gillis-Paulgaard
Phone:
(780) 487 1600
E-mail:
sgillis-paulgaard@isotechnika.com
Web:
www.isotechnika.com
Isotechnika Inc. is a biopharmaceutical company focused on the discovery and development of novel immunosuppressive therapeutics that are safer than currently available treatments. Isotechnika's lead compound is ISA247, a new calcineurin inhibitor with a different metabolic profile than cyclosporine. ISA247 has completed a Canadian Phase 3 trial and commenced a European/Canadian Phase 3 trial for the treatment of moderate to severe psoriasis. A Phase 2b trial using ISA247 for the prevention of kidney graft rejection has also commenced in North America. Additionally, Isotechnika has developed TAFA93, a novel prodrug of the mTOR inhibitor rapamycin. TAFA93 has successfully completed Phase 1 trials.
Company:
ISTO Technologies, Inc.
Media Contact:
Mitchell Seyedin Ph.D.
Phone:
314-995-6049
E-mail:
314-995-6025
Web:
www.istotech.com
ISTO Technologies, Inc, St. Louis, Missouri, is a clinical stage orthobiologic company focused on developing differentiated products for sports medicine and spinal therapy. ISTO's products in development are intended for repair and regeneration of bone and cartilage tissues in knee joints and spine. ISTO's lead cartilage product in phase I/II clinical trials is DeNovo-ET® in partnership with Zimmer, Inc. DeNovo- Et is a living tissue-engineered graft for the restoration of cartilage defects in the knee. Also under development are: NuQu™ injectable juvenile cartilage cells for spinal disc repair; and InQu™ a tissue-engineered scaffold for bone and other soft tissue repair.
Company:
Iter srl
Booth:
2025 Italy Pavillon
Media Contact:
Domenico Piazza
Phone:
39 02 2831161
E-mail:
bioforum@iter.it
Web:
www.iter.it/en
Starting from 2004 bioforum is the meeting between science and business in Italy. Visit the web site www.bioforum.it/en, look the masterplan www.bioforum.it/2006/english/conference.htm , the committee www.bioforum.it/2006/english/committee.htm, previous editions www.bioforum.it/english/previous.htm.
Since 1989 ITER creates tailoring services for the scientific and business world. ITER organizes successful Seminars, Congresses and Exhibitions on innovative topics, such as biotechnologies, nanotechnologies, computer science and communication by using a rich and updated database.
ITER edits specialized publication concerning the ICT world dedicated to the professional field, and publishes services by writing and printing specialized contents: research, handbooks, books and brochure, even in limited edition.
Company:
Japan External Trade Organization (JETRO)
Booth:
2549
Media Contact:
Taku Sato
Phone:
(212)-997-0400
E-mail:
Taku_Sato@jetro.go.jp
Web:
http://www.jetro.org/
Japan External Trade Organization (JETRO) has organized a Japan Pavilion, consisting of 32 Japanese biotech companies, at BIO 2007. We are also offering one-on-one meetings with these companies, to facilitate future international partnerships and collaborations.
In addition, we have organized two seminars at BIO 2007:
--"Agricultural R&D in Biomass Conversion for Renewable Energy,"
--"Partnering with Japanese Biotech," which will focus on new opportunities for partnerships.
These seminars will provide in-depth look at current state of Japanese biotech industry.
For more information on Japan Pavilion participants, and JETRO's activities at BIO 2007, please check: http://www.jetro.org/bio2007.
Company:
J. Calnan & Associates, Inc.
Booth:
#533/A19
Media Contact:
Michelle Elchaak
Phone:
617-801-0252
E-mail:
melchaak@jcalnan.com
Web:
www.jcalnan.com
J. Calnan & Associates, Inc. (JC&A), headquartered in Quincy, MA with an office in NYC, is one of New England's leading construction management firms specializing in world-class pre-construction consulting, project management, facilities maintenance, and construction projects in the life science industry. JC&A has excelled at working in challenging GMP environments including occupied spaces, challenging user groups, and strict security requirements and demanding schedules. Our team will ensure that the critical issues regarding material selection and availability, quality assurance, safety, security and milestones are understood.
Our clients include Wyeth Pharmaceuticals, Acceleron Pharma, Draper Laboratory, Parexel and Millipore Corporation. Visit website: www.jcalnan.com.
Company:
Joulé Scientific Staffing Solutions
Booth:
1967
Media Contact:
Mary Jane Martin
Phone:
800-382-0382 x418
E-mail:
mjmartin@jouleinc.com
Web:
www.joulescientific.com
For over a decade, Joulé has defined the market for Scientific Staffing. Joulé Scientific delivers the best solution for each biotechnology, pharmaceutical, chemical, and clinical research organization. Joulé has developed the perfect process for finding that perfect employee. From the discovery phase to strategy and planning, through execution and onto results, there is a single mission -- providing the perfect employee. Our systematic yet customizable method relies heavily on the experience of trained professionals and technology based tools. This market-defining process and service not only provides positive results toda
Source: Business Wire
Related Articles
- Plasco forms R&D partnership - Plasco Energy Group Inc and Lowe, Gravelle & Associates form Plasco LG Research and Development Services Inc.
- PSI Wins Clinical Data Mart Development Services Contract From TMA DHSS
- Suresh Babu Joins Elcoteq India As Communications Networks Product Development Services Director
- Cell Phones Vital in Developing World
- Kentucky School Districts Purchase Carnegie Learning Professional Development Services; Emphasis on Advancing Math Education Opportunities and Standards Leads 31 Districts to Research-Based Professional Development Model
- Linda H. Aiken, PhD, Selected As the Inaugural Recipient of the William B. Graham Prize for Health Services Research
- Pramati Announces Launch of Product Development Services Division; Leveraging Its Proven Capabilities in Product Development
- Cordiant Technologies Announces Outsourced Product Development Services for Small and Mid-Sized ISVs; India-Based Solutions Provider Offers Cost Effective, Flexible Options for Software Vendors
- Research and Markets: India's Pharmaceutical, Life Sciences and Medical Equipment Markets in the Throes of Rapid Modernization
- Chemicon International, Inc. Enters into a License to Commercialize Research Products Utilizing Human Embryonic Stem Cell Technology From Wisconsin Alumni Research Foundation (WARF)
 |
 |
User Comments (0)
RSS Feeds